Delivery Order SPE2DB20D3101-SPE2DB24FRQT4

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Naltrexone 50 mg tablets. The $5,204.37 firm fixed price contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,560.84, is a Firm Fixed Price Delivery Order for the supply of 60-count Naltrexone 50 mg tablets. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,586.59 firm fixed-price delivery order contract is for the supply of naltrexone 50 mg tablets to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, which covers a broad range of...
This federal contract award, valued at $31,508.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of Naltrexone 50 mg tablets to support military healthcare programs. This pharmaceutical product is used in the treatment of opioid and alcohol dependence. The contract has...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,545.05 firm-fixed-price delivery order is for the supply of 60-count bottles of 50 mg Naltrexone tablets, a medication used to treat opioid and alcohol dependence. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FT4Z0) for the supply of 4,556,398 units of Naltrexone 50 mg tablets. The $4,174.44 firm fixed-price award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has a period of performance through March 1, 2022 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of NALTREXONE 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,111.51 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 27, 2025, with a performance period running through March 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $23,568.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567342575 ! NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has an ultimate completion date of February 24, 2025 and a firm fixed price pricing type. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,573.18 firm fixed price delivery order is for the supply of Naltrexone 50 mg tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves...
This federal contract award, SPE2DB20D3505|SPE2DB25FT9E7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,118,963 units of Naltrexone 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,813.91 and a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRQT4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.24 firm fixed-price delivery order is for the supply of 60-count tablets of the medication Naltrexone 50mg. The contract has an ultimate completion date of July 25, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies. The reviewed contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:35 AM